These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6547139)

  • 21. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.
    Azizeh BY; Ahn JM; Caspari R; Shenderovich MD; Trivedi D; Hruby VJ
    J Med Chem; 1997 Aug; 40(16):2555-62. PubMed ID: 9258362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Coy D; Christophe J
    Peptides; 1984; 5(5):877-81. PubMed ID: 6504721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity studies on the N-terminal region of glucagon.
    Sueiras-Diaz J; Lance VA; Murphy WA; Coy DH
    J Med Chem; 1984 Mar; 27(3):310-5. PubMed ID: 6699876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27.
    Unson CG; Gurzenda EM; Iwasa K; Merrifield RB
    J Biol Chem; 1989 Jan; 264(2):789-94. PubMed ID: 2536024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of histidine-1 in glucagon action.
    Unson CG; Macdonald D; Merrifield RB
    Arch Biochem Biophys; 1993 Feb; 300(2):747-50. PubMed ID: 8382034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation of predicted structure to observed conformation and activity of glucagon analogs containing replacements at positions 19, 22, and 23.
    Murphy J; Zhang WJ; Macaulay W; Fasman G; Merrifield RB
    J Biol Chem; 1987 Dec; 262(36):17304-12. PubMed ID: 3693354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reaction of glucagon with its receptor: evidence for discrete regions of activity and binding in the glucagon molecule.
    Rodbell M; Birnbaumer L; Pohl SL; Sundby F
    Proc Natl Acad Sci U S A; 1971 May; 68(5):909-13. PubMed ID: 5280527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors.
    Azizeh BY; Van Tine BA; Trivedi D; Hruby VJ
    Peptides; 1997; 18(5):633-41. PubMed ID: 9213355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
    Hruby VJ; Gysin B; Trivedi D; Johnson DG
    Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational and biological properties of a covalently linked dimer of glucagon. Reaction of mono- and bifunctional sulfenyl halides.
    Epand RM; Cote TE
    Biochim Biophys Acta; 1976 Dec; 453(2):365-73. PubMed ID: 999894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivatives.
    Heithier H; Ward LD; Cantrill RC; Klein HW; Im MJ; Pollak G; Freeman B; Schiltz E; Peters R; Helmreich EJ
    Biochim Biophys Acta; 1988 Oct; 971(3):298-306. PubMed ID: 2844291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of the C-terminal alpha-helical structure for glucagon's biological activity.
    Krstenansky JL; Zechel C; Trivedi D; Hruby VJ
    Int J Pept Protein Res; 1988 Dec; 32(6):468-75. PubMed ID: 2854536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation.
    Hoang HN; Bryant GK; Kelso MJ; Beyer RL; Appleton TG; Fairlie DP
    Inorg Chem; 2008 Oct; 47(20):9439-49. PubMed ID: 18788796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Van Tine BA; Azizeh BY; Trivedi D; Phelps JR; Houslay MD; Johnson DG; Hruby VJ
    Endocrinology; 1996 Aug; 137(8):3316-22. PubMed ID: 8754757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational determinants in receptor recognition of peptide hormones: interaction of parathyroid hormone with the glucagon receptor.
    Shah GV; Epand RM; Orlowski RC
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):203-10. PubMed ID: 3030852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (Des-histidine 1) (N epsilon-phenylthiocarbamoyllysine 12)-glucagon: effects on glycogenolysis in perfused rat liver.
    Khan BA; Bregman MD; Nugent CA; Hruby VJ; Brendel K
    Biochem Biophys Res Commun; 1980 Apr; 93(3):729-36. PubMed ID: 7387671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.